Ide Armelle Djuidje Chatue: Unveiling EBV’s Role in Malaria Susceptibility
Ide Armelle Djuidje Chatue, PHD Student in Medical Microbiology at University of Yaounde, shared a post on LinkedIn about a paper published in Scientific Reports:
“Proud to share my latest publication in Nature Scientific Reports titled ‘Impact of Epstein–Barr virus reactivation on cytokine levels in pregnant women with malaria in the West Region of Cameroon.’
This study offers important insight into the immunological mechanisms through which Epstein–Barr virus, one of the most common oncogenic viruses, may modulate antimalarial immune responses and increase susceptibility to severe malaria during pregnancy. The findings provide new perspectives for strengthening maternal health and malaria management in endemic regions, while underscoring the role of EBV as a potential cofactor in disease progression.
Grateful to my collaborators and all who contributed to this research.
Maximilienne A. Nyegue, Severin Donald Kamdem, Taya Fokou Jean Bosco, Armando Djiyou, Arnaud Tepa, Roy Roger F., Iqbal Taliy Junaid, Pawan Malhotra, Palmer Masumbe Netongo
Read the full article here.”
Title: Impact of epstein-barr virus reactivation on cytokine levels in pregnant women with malaria in the west region of cameroon
Authors: Ide Armelle Djuidje Chatue, Maximilienne Ascension Nyegue, Severin Donald Kamdem, Jean Bosco Taya-Fokou, Armando Blondel Djeuda Djiyou, Eric Berenger Tchoupe, Arnaud Tepa, Roger Fuh Neba, Iqbal Taliy Junaid, Pawan Malhotra, Palmer Masumbe Netongo
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Nov 2, 2026, 17:08Elena Milner: The 2nd Class of the School of Embryology Is Already in Full Swing
-
Nov 2, 2026, 17:05November Is National Diabetes Month – PCOS Awareness Association
-
Nov 2, 2026, 17:04Thanos Papathanasiou: Are We Preparing Patients for the IVF Cycle, or for the IVF Journey?
-
Nov 2, 2026, 17:02Anna Morales: Why Is It So Hard to Build in Women’s Health?
-
Nov 2, 2026, 16:59Rickard Ericsson: Honored to Take on the Role of Interim CEO of the Vitrolife Group
-
Nov 2, 2026, 16:56Mohammed Nasur: 1 Small Simulation, A Bigger Purpose
-
Nov 2, 2026, 16:54Carlos Guerrero: Presenting Our Latest Research on AI and Embryo Assessment at ASRM 2026
-
Nov 2, 2026, 16:52Sarah Lewen: My 1st ASRM Is Officially Complete
-
Nov 2, 2026, 16:49Jemma Garratt: Taking on the Role of Kind IVF and Data Science Manager at London Women’s Clinic